PharmaZell
GermanyEntry
2020
Hold
6yr
Status
Active
Who owns PharmaZell?
PharmaZell is currently owned by Bridgepoint through Europe VI (BE VI) (2017 vintage), since 2020. Across its history, PharmaZell has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-03
Most recent investor
BridgepointEurope VI (BE VI) · 2017 · Buyout
4 ownership periods · full history below
Key facts
HQGermany
SectorPharma
StatusAcquired
Key takeaways
- ·Held by Bridgepoint since 2020 (6Y hold).
- ·Average hold across 3 realized cycles: 6 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Auctus Capital PartnersExited 2011
2006 · 2011(5yr) · Auctus I (Evergreen) · 2003 · Buyout
Secondary · to
MOIC
–
Co-invest · 2 holders · 2014 · 2020
Maxburg Capital PartnersExited 2020
2014 · 2020(6yr) · Maxburg Beteiligungen · 2014 · Buyout
Secondary · to
MOIC
–
BridgepointActive
2020 · present(6yr) · Europe VI (BE VI) · 2017 · Buyout
More from Europe VI (BE VI)
Other portfolio companies in the same fund.
Netherlands
Ireland
Switzerland
France
USMore PE-backed in Pharma
Comparable pharma deals from other GPs.
Track PharmaZell
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy PharmaZell?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on PharmaZell.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue